Menu

Blog

Page 3708

Jul 1, 2022

Central Dogma

Posted by in categories: biotech/medical, genetics

The central dogma of molecular biology explains the flow of genetic information, from DNA to RNA, to make a functional product, a protein.


This Video Explains Central Dogma.

Continue reading “Central Dogma” »

Jul 1, 2022

GridRaster Uses the Metaverse to Build High Tech Prototypes and Finished Products

Posted by in categories: augmented reality, mapping, robotics/AI, transportation, virtual reality

An Interview with COO Dijam Panigrahi.


“a unified and shared software infrastructure to empower enterprise customers to build and run scalable, high-quality eXtended Reality (XR) – Augmented Reality (AR), Virtual Reality (VR) and Mixed Reality (MR) – applications in public, private, and hybrid clouds.”

What does that all mean?

Continue reading “GridRaster Uses the Metaverse to Build High Tech Prototypes and Finished Products” »

Jul 1, 2022

Brain-computer interface technology opens up “whole new world” of therapies

Posted by in categories: biotech/medical, computing, cyborgs, neuroscience

“We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells NeuroNews, referring to the potential of brain-computer interface (BCI) technology. Alongside his role as a vascular and interventional neurologist, Oxley is chief executive officer of Synchron, developer of the Stentrode motor neuroprosthesis. The Stentrode is an implantable BCI device that, according to Oxley, is the first of its kind to be in the early feasibility clinical stage in the USA following US Food and Drug Administration (FDA) approval of Synchron’s investigational device exemption (IDE) application last month. Speaking to NeuroNewsfollowing a presentation on the topic at the Society of NeuroInterventional Surgery’s 18thannual meeting (SNIS; 26–29 July 2021, Colorado Springs, USA and virtual), Oxley gives an overview of the COMMAND early feasibility study, anticipates key results, and considers more generally how BCI technology could shape the future of deep brain stimulation.

Jul 1, 2022

Looking Beyond 2050 — On Earth and in Space with Lord Martin Rees

Posted by in categories: biotech/medical, business, education, evolution, food, health, media & arts, neuroscience

Cosmologist, noted author, Astronomer Royal and recipient of the 2015 Nierenberg Prize for Science in the Public Interest Lord Martin Rees delivers a thought-provoking and insightful perspective on the challenges humanity faces in the future beyond 2050. [3/2016] [Show ID: 30476]

Frontiers of Knowledge.
(https://www.uctv.tv/frontiers-of-knowledge)

Continue reading “Looking Beyond 2050 — On Earth and in Space with Lord Martin Rees” »

Jul 1, 2022

Fermi Paradox: The Great Filter is Near

Posted by in category: existential risks

Anything not forbidden is mandatory quote by TH white once and future king.


An exploration of the notion that extinction by unforeseen means is a solution to the Fermi Paradox and that all civilizations in the universe blunder into extinction without seeing it coming.

Continue reading “Fermi Paradox: The Great Filter is Near” »

Jul 1, 2022

10 SETI Messages That We May Not Want to Receive

Posted by in category: alien life

An exploration of alternative SETI messages that may not say hello.

https://www.patreon.com/johnmichaelgodier.

Continue reading “10 SETI Messages That We May Not Want to Receive” »

Jul 1, 2022

Experimental drug reverses synaptic loss in mouse models of Alzheimer’s

Posted by in categories: biotech/medical, neuroscience

An experimental drug restored brain synapses in two mouse models of Alzheimer’s disease, raising hopes that it could help revive cognitive function in human dementia patients, Yale University researchers report June 1 in the journal Science Translational Medicine.

While much research in Alzheimer’s has centered on reducing levels of beta-amyloid plaque in the brain that is a hallmark of the , recent studies have suggested that immune system response in the brain also plays a role in in patients.

Some scientists now believe that cognitive decline in Alzheimer’s patients results from a loss of synaptic connections between neurons caused by a steady accumulation of beta-amyloid protein in the brain which in turn unleashes a chronic immune system response to the intruder. The end stages of the disease lead to the death of neurons.

Jul 1, 2022

A geomagnetic storm hit Earth at a million miles an hour and nobody saw it coming

Posted by in category: robotics/AI

Jul 1, 2022

Where are the flying cars? Why a century-old dream still hasn’t taken off

Posted by in category: transportation

Jul 1, 2022

New Algorithm Can Predict Crime in US Cities a Week Before It Happens

Posted by in category: information science